By Daniel Baldwin
April 18, 2025
(Views expressed by guest commentators may not reflect the views of OAN or its affiliates.)
By Daniel Baldwin
April 18, 2025
(Views expressed by guest commentators may not reflect the views of OAN or its affiliates.)
Donald Trump is not happy with Jerome Powell.
Trump called him out over recent comments he made that sent the stock market lower.
Trump said Powell is “always TOO LATE AND WRONG” and that “Powell’s termination cannot come fast enough!”
The ECB is expected to cut interest rates for the 7th time, and yet, “Too Late” Jerome Powell of the Fed, who is always TOO LATE AND WRONG, yesterday issued a report which was another, and typical, complete “mess!” Oil prices are down, groceries (even eggs!) are down, and the USA is getting RICH ON TARIFFS. Too Late should have lowered Interest Rates, like the ECB, long ago, but he should certainly lower them now. Powell’s termination cannot come fast enough!
Inflation fell lower than expected in March.
The 12-month inflation rate hit 2.4%, down from 2.8% in February.
Consumer price inflation eased more than expected in March as President Donald Trump prepared to launch tariffs against U.S. trading partners, the Bureau of Labor Statistics reported Thursday.
The consumer price index, a broad measure of goods and services costs across the U.S. economy, fell a seasonally adjusted 0.1% in March, putting the 12-month inflation rate at 2.4%, down from 2.8% in February.
Excluding food and energy, so-called core inflation ran at a 2.8% annual rate, having increased 0.1% for the month. That was the lowest rate for core inflation since March 2021.
Wall Street had been looking for headline inflation of 2.6% and core at 3%, according to the Dow Jones consensus.
Time to cut rates!
Another world leader is meeting with Donald Trump to make a deal.
Italian Prime Minister Giorgia Meloni is meeting with Donald Trump on Thursday.
Italian Prime Minister Giorgia Meloni is expected to meet with President Donald Trump on Thursday in a move to ease tensions and play intermediary between the White House and the European Union amid the litany of tariffs the president has levied against the bloc.
…
But the Italian leader is believed to have more on her mind than maintaining positive relations with Trump. She is looking to lead the charge in protecting the EU’s economy.
“I think the Europeans see this as an opportunity, not a pitfall. Meloni is perfectly positioned to serve as a transatlantic bridge between Brussels and Washington,” Peter Rough, senior fellow and director for the Center on Europe and Eurasia with the Hudson Institute, told Fox News Digital.
“She has good relations with Ursula von der Leyen, the president of the [European Union] Commission and is a natural fit for Trump, given their mutual national conservatism,” he added.
Trump gave an update on his tariff meetings early on Thursday.
Had a very productive call with the President of Mexico yesterday. Likewise, I met with the highest level Japanese Trade Representatives. It was a very productive meeting. Every Nation, including China, wants to meet! Today, Italy!
Deals are being worked on!
Countries want to make deals over tariffs.
Donald Trump revealed that he will attend a meeting with Japan to negotiate “Tariffs, the cost of military support, and TRADE FAIRNESS.”
Japan is coming in today to negotiate Tariffs, the cost of military support, and “TRADE FAIRNESS.” I will attend the meeting, along with Treasury & Commerce Secretaries. Hopefully something can be worked out which is good (GREAT!) for Japan and the USA!
Japan was hit with a 24% tariff, which is currently 10% due to the 90-day pause.
Japan has been hit with 24% levies on its exports to the United States although these rates have, like most of Trump’s tariffs, been paused for 90 days. But a 10% universal rate remains in place as does a 25% duty for cars, a mainstay of Japan’s export-reliant economy.
Tokyo’s top trade negotiator, Ryosei Akazawa, will meet Trump’s Treasury Secretary Scott Bessent and Trade Representative Jamieson Greer for discussions that could also address energy projects and the thorny issue of exchange rates.
Art of the deal.
By Theodore R. Malloch
April 16, 2025
(Views expressed by guest commentators may not reflect the views of OAN or its affiliates.)
By Theodore R. Malloch
April 16, 2025
(Views expressed by guest commentators may not reflect the views of OAN or its affiliates.)
The Kennedy Center broke its all-time attendance record on March 29th.
The EARTH to SPACE: Arts Breaking the Sky fireworks show had over 11,000 attendees.
The Kennedy Center broke its all-time attendance record for a public event March 29, with over 11,000 attendees for the EARTH to SPACE: Arts Breaking the Sky fireworks show, the Daily Caller has exclusively learned.
The history-making moment was celebrated amid a flurry of criticism from liberals about President Donald Trump’s takeover of the entertainment facility. Critics voiced concerns about Trump’s understanding and appreciation for the arts when he took control of the Kennedy Center. However, attendance numbers have told a different story. With a focus on shifting away from politically-charged programming, the facility experienced tremendous success with a widely-attended fireworks show.
…
A Kennedy Center representative noted that 76% of all attendees at the fireworks show had never stepped foot in the venue before. The event was open to the public, with free first-come, first-served tickets available on the Kennedy Center website.
Donald Trump celebrated the news in a post on Truth Social.
Trump wrote, “Thank you very much to all of the Record Setting Attendees! We are spending a lot of time, effort, and money on making The Kennedy Center the spectacular venue that it was originally meant to be.”
Thank you very much to all of the Record Setting Attendees! We are spending a lot of time, effort, and money on making The Kennedy Center the spectacular venue that it was originally meant to be. Bear with us, it’s happening faster than expected. The crowds are fantastic, nothing will keep them away!
Another big success!
The FDA is replacing “animal testing in the development of monoclonal antibody therapies and other drugs with more effective, human-relevant methods.”
According to the FDA, “The FDA’s animal testing requirement will be reduced, refined, or potentially replaced using a range of approaches, including AI-based computational models of toxicity and cell lines and organoid toxicity testing in a laboratory setting (so-called New Approach Methodologies or NAMs data).”
Today, the U.S. Food and Drug Administration is taking a groundbreaking step to advance public health by replacing animal testing in the development of monoclonal antibody therapies and other drugs with more effective, human-relevant methods. The new approach is designed to improve drug safety and accelerate the evaluation process, while reducing animal experimentation, lowering research and development (R&D) costs, and ultimately, drug prices.
The FDA’s animal testing requirement will be reduced, refined, or potentially replaced using a range of approaches, including AI-based computational models of toxicity and cell lines and organoid toxicity testing in a laboratory setting (so-called New Approach Methodologies or NAMs data). Implementation of the regimen will begin immediately for investigational new drug (IND) applications, where inclusion of NAMs data is encouraged, and is outlined in a roadmap also being released today. To make determinations of efficacy, the agency will also begin use pre-existing, real-world safety data from other countries, with comparable regulatory standards, where the drug has already been studied in humans.
“For too long, drug manufacturers have performed additional animal testing of drugs that have data in broad human use internationally. This initiative marks a paradigm shift in drug evaluation and holds promise to accelerate cures and meaningful treatments for Americans while reducing animal use,” said FDA Commissioner Martin A. Makary, M.D., M.P.H. “By leveraging AI-based computational modeling, human organ model-based lab testing, and real-world human data, we can get safer treatments to patients faster and more reliably, while also reducing R&D costs and drug prices. It is a win-win for public health and ethics.”
PETA thanked the Trump administration for the move.
They wrote, “PETA thanks the Trump administration for modernizing the FDA and helping spare tens of thousands of animals each year from being killed in expensive and archaic laboratory tests.”
The White House Press Secretary is highlighting this milestone!
PETA thanks the Trump administration for modernizing the FDA and helping spare tens of thousands of animals each year from being killed in expensive and archaic laboratory tests. https://t.co/unLYYNplMh
— PETA (@peta) April 14, 2025
PETA, which has blasted health officials such as Dr. Anthony Fauci for past animal testing, released a positive statement in response to the Trump administration’s recent policy directives.
“PETA applauds the FDA’s decision to stop harming animals and adopt human-relevant testing strategies for evaluating antibody therapies,” PETA senior vice president Kathy Guillermo said.
“It’s a significant step towards meeting the agency’s commitment to replace the use of animals – which PETA has worked hard to promote. All animal use, including failed vaccine and other testing on monkeys at the federally-funded primate centers, must end, and we are calling on the FDA to further embrace 21st-century science,” the statement continued.
Even PETA is backing one of Trump’s policies!
Note: The information provided here or in any related communications is for informational purposes only and should not be considered as financial advice. We do not provide personalized investment, financial, or legal advice. Pro Trump News benefits from purchases made through our sponsors.
(Note: Thank you for supporting businesses like the one presenting a sponsored message below and working with them through the links below which benefits Pro Trump News. We appreciate your support!)
In a candid conversation on comedian Joe Rogan’s podcast, the Braveheart star revealed that two of his close friends, who had been battling stage 4 cancer, experienced remarkable recoveries after using ivermectin and fenbendazole—drugs commonly employed to treat parasitic infections like roundworms and threadworms.
Gibson went on to make a bold statement, claiming that all three friends who tried these medications “don’t have cancer right now.” He emphatically added, “This stuff works, man.” While these claims have sparked interest, experts urge caution, as scientific evidence supporting the use of these drugs for cancer treatment remains in its infancy.
Some preliminary studies hint at potential benefits. For instance, ivermectin, when combined with other therapies, has been found to shrink tumors in early research, though such findings are yet to be validated by larger clinical trials. Similarly, fenbendazole—marketed under brand names such as Panacur and Safe-Guard—has shown promise in laboratory studies by halting the growth of certain aggressive cancer cells.
Note: The information provided on this website is intended for informational purposes only and should not be considered medical advice or used as a substitute for professional healthcare guidance. It is your responsibility to comply with all applicable laws, regulations, and guidelines regarding the purchase, possession, and use of prescription medications.